The control of allergic conjunctivitis by suppressor of cytokine signaling (SOCS)3 and SOCS5 in a murine model.
about
Ragweed-induced allergic rhinoconjunctivitis: current and emerging treatment options.Lower expression of TLR2 and SOCS-3 is associated with Schistosoma haematobium infection and with lower risk for allergic reactivity in children living in a rural area in GhanaAntiallergic effect of an aqueous leaf extract of Pistia stratiotes in murine model of ovalbumin-induced allergic conjunctivitis.The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2.SOCS2 regulates T helper type 2 differentiation and the generation of type 2 allergic responses.Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection.Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in miceInterleukin 10 and transforming growth factor beta contribute to the development of experimentally induced allergic conjunctivitis in mice during the effector phase.Curcumin suppresses ovalbumin-induced allergic conjunctivitisSuppressor of cytokine signalling 1 (SOCS1) is a physiological regulator of the asthma responsePossible Mechanism of Action of the Antiallergic Effect of an Aqueous Extract of Heliotropium indicum L. in Ovalbumin-Induced Allergic ConjunctivitisSuppressor of cytokine signaling 3 (SOCS3) in Th2 cells evokes Th2 cytokines, IgE, and eosinophilia.New drugs targeting Th2 lymphocytes in asthma.SOCS regulation of the JAK/STAT signalling pathway.Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function.SOCS3, a Major Regulator of Infection and Inflammation.Regulation of CD4+ T-cell polarization by suppressor of cytokine signalling proteins.Different partners, opposite outcomes: a new perspective of the immunobiology of indoleamine 2,3-dioxygenase.SOCS proteins in development and disease.Type 2 cytokines: mechanisms and therapeutic strategies.SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?Ameliorative effect of thymoquinone on ovalbumin-induced allergic conjunctivitis in Balb/c mice.SOCS-3 inhibits E2F/DP-1 transcriptional activity and cell cycle progression via interaction with DP-1Conjunctival mast cell as a mediator of eosinophilic response in ocular allergy.Conjunctival macrophages act as antigen-presenting cells in the conjunctiva during the development of experimental allergic conjunctivitis.Clinical implications of mast cell involvement in allergic conjunctivitis.Sub-pathway analysis for severe burns injury patients: Identification of potential key lncRNAs by analyzing lncRNA-mRNA profile.
P2860
Q30903098-B36EF6E8-8FD1-48EE-A0E0-2E1E49D19E10Q33328464-56A3F6A9-C821-428F-A5A2-8D5656932AD6Q34201383-571462AD-0D29-424B-8FEC-D96172043BDCQ34801853-964F482B-413B-42DF-928B-55351EDC497AQ35102288-8990C778-E293-4966-B6D7-0F7F3AB98371Q35459801-C4F1F0D6-6377-4881-86AF-9C5E98ACEB7EQ35762001-3D626812-7C8B-43D0-ABD2-974A2C3A9BB2Q35762746-9ED6718C-4117-4D3C-B81D-295E426C890BQ36146027-D8B24481-C2C2-4E04-BE7F-188E4E29F6FBQ36253193-0F01003C-7237-4696-9F80-912EEE19D769Q36310301-D79263FB-E4AD-40CE-8123-97EC1E8685AEQ36395750-D143D054-3C23-4429-BFF8-52D7433A1015Q36485165-6012E825-DF67-4E7B-9306-79E89322489EQ37003892-7AD92411-5145-4419-B895-520B7CF9379BQ37455362-9DF37A08-D450-4FAB-9107-14599F1FAB29Q37592325-02AEB31F-9C2F-482B-BDF8-7AAFA118513CQ37951621-C20C48CC-5EE7-4A4E-A18E-2F876ECA7C26Q38000471-D93E03C1-A91A-4EC6-A8B6-058529F3ADD4Q38124037-24E4618C-5D5C-45C0-B121-2E922336D7E4Q38424752-B2969B36-0547-495F-807A-91F51FA57591Q38823319-B24270FE-B21D-4DC1-9B62-FA05AD079C00Q39747429-2255F1F0-17A1-4EC1-A14D-F8233F9252EDQ39952868-540A020A-3D06-4DBE-8ABC-E17D931869A7Q41837279-C617D4A2-CA33-4448-93C2-CBE25A578DDAQ42733204-FF25C932-AA07-48A6-8DEE-9A46ABA7C5E6Q48361100-8687EEC1-6D5A-4613-B0F5-212DE41F4EE3Q55222787-D0823F67-7C82-4372-A9B5-69B30194DACA
P2860
The control of allergic conjunctivitis by suppressor of cytokine signaling (SOCS)3 and SOCS5 in a murine model.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The control of allergic conjun ...... 3 and SOCS5 in a murine model.
@ast
The control of allergic conjun ...... 3 and SOCS5 in a murine model.
@en
The control of allergic conjunctivitis by suppressor of cytokine signaling
@nl
type
label
The control of allergic conjun ...... 3 and SOCS5 in a murine model.
@ast
The control of allergic conjun ...... 3 and SOCS5 in a murine model.
@en
The control of allergic conjunctivitis by suppressor of cytokine signaling
@nl
prefLabel
The control of allergic conjun ...... 3 and SOCS5 in a murine model.
@ast
The control of allergic conjun ...... 3 and SOCS5 in a murine model.
@en
The control of allergic conjunctivitis by suppressor of cytokine signaling
@nl
P2093
P1476
The control of allergic conjun ...... 3 and SOCS5 in a murine model.
@en
P2093
Akemi Ozaki
Atsuki Fukushima
Masato Kubo
Yoh-ichi Seki
P304
P356
10.4049/JIMMUNOL.175.8.5489
P407
P577
2005-10-01T00:00:00Z